Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 74, Issue 3

Impact of cyclosporine A on the progression of ocular surface diseases: treatment efficacy and potential complications Open Access

Abstract

Eye diseases are widespread all over the world and, if left untreated, can lead to blindness.

The use of 0.05% cyclosporine A (CsA) solution for the treatment of dry eye causes a decrease in discomfort and pain and improves objective measures such as tear film breakdown time, Schirmer test results and Oxford scale scores due to its anti-inflammatory and immunomodulatory properties that contribute to improved tear film stability and tear production.

This study aimed to investigate the impact of CsA on the progression of ocular surface diseases.

An experiment was conducted on the basis of the FOCUS ophthalmology centre, Kazakhstan. A group of 100 individuals diagnosed with mild to severe dry eye illness were administered 0.05% CsA eye drops as part of the treatment protocol.

The positive effect is explained by the anti-inflammatory and immunomodulatory effects of CsA. The study showed that the use of 0.05% CsA solution for the treatment of ocular surface disease led to a decrease in discomfort and pain, as well as an improvement in objective measures, including tear film breakdown time, Schirmer test results and Oxford scale scores. The visual analogue scale showed a significant reduction in symptoms, from 6.8 points at baseline to 3.7 points at day 60. In total, 20% of patients reported moderate side effects, such as pain during instillation and redness of the eye surface.

It is concluded that the use of these drops reduced pain, improved patient condition and enhanced indicators such as the visual analogue scale, tear film breakup time, Schirmer test and Oxford scale of corneal and conjunctival staining. This study differs from the previous ones in that it focuses on the efficacy of 0.05% CsA solution in the treatment of dry eye and also examines the spectrum and frequency of side effects, which is not sufficiently covered in previous studies.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): conjunctiva , dysfunctional tear syndrome , inflammation , Meibomian gland and Schirmer test
© 2025 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001978
2025-03-12
2026-01-14

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/jmm/74/3/jmm001978.html?itemId=/content/journal/jmm/10.1099/jmm.0.001978&mimeType=html&fmt=ahah

References

  1. Tashtitova LB, Auyezova AM, Kulmaganbetov M. Population-based screening leads to improved glaucoma diagnosis in Kazakhstan. Cogent Public Health 2023; 10:2191377 [View Article]
     [Google Scholar]
  2. Kamenova SU, Aralbayeva AD, Iskakova SA, Kondybayeva AM, Kuzhybayeva KK et al. Non-motor visual disorders in Kazakhstan patients with Parkinson’s disease. Interdiscipl App Med 2021; 2: [View Article]
     [Google Scholar]
  3. Mukazhanova A, Aldasheva N, Iskakbayeva J, Bakhytbek R, Ualiyeva A et al. Prevalence of refractive errors and risk factors for myopia among schoolchildren of Almaty, Kazakhstan: a cross-sectional study. PLoS One 2022; 17:e0269474 [View Article] [PubMed]
     [Google Scholar]
  4. Kabylbekova A, Meirmanov S, Aringazina A, Orazbekov L, Auyezova A. Clinical characteristics of congenital and developmental cataract in Kazakhstan. Indian J Ophthalmol 2022; 70:4325–4330 [View Article] [PubMed]
     [Google Scholar]
  5. Karabalayeva AB, Ibadullayeva SZ, Beisembaevna AS. Monitoring of the visual system of students in the Southern Region of Kazakhstan and the implementation of the results in the methods of teaching biology. Int J Educ Rev 2021; 3:103–123 [View Article]
     [Google Scholar]
  6. Gyenes A, Tapasztó Z, Quirce S, Luna C, Frutos-Rincón L et al. Cyclosporine A decreases dryness-induced hyperexcitability of corneal cold-sensitive nerve terminals. Int J Mol Sci 2023; 24:13025 [View Article] [PubMed]
     [Google Scholar]
  7. Nguyen DD, Lai J-Y. Advancing the stimuli response of polymer-based drug delivery systems for ocular disease treatment. Polym Chem 2020; 11:6988–7008 [View Article]
     [Google Scholar]
  8. Gao D, Da Z, Yang K, Shi Y. Comparison of seven cyclosporine A formulations for dry eye disease: a systematic review and network meta-analysis. Front Pharmacol 2022; 13:882803 [View Article] [PubMed]
     [Google Scholar]
  9. Ekici E, Caglar C, Akgümüş EÜ. The repeatability, reproducibility, and correlation of the Schirmer test: a comparison of open versus closed eye. Korean J Ophthalmol 2022; 36:306–312 [View Article] [PubMed]
     [Google Scholar]
  10. Kim YH, Graham AD, Li W, Radke CJ, Lin MC. Human lacrimal production rate and wetted length of modified Schirmer’s tear test strips. Transl Vis Sci Technol 2019; 8:40 [View Article] [PubMed]
     [Google Scholar]
  11. Fernández-Jimenez E, Diz-Arias E, Peral A. Improving ocular surface comfort in contact lens wearers. Cont Lens Anterior Eye 2022; 45:101544 [View Article] [PubMed]
     [Google Scholar]
  12. Yang C-J, Anand A, Huang C-C, Lai J-Y. Unveiling the power of gabapentin-loaded nanoceria with multiple therapeutic capabilities for the treatment of dry eye disease. ACS Nano 2023; 17:25118–25135 [View Article] [PubMed]
     [Google Scholar]
  13. Bui HL, Su YH, Yang CJ, Huang CJ, Lai JY. Mucoadhesive, antioxidant, and lubricant catechol-functionalized poly(phosphobetaine) as biomaterial nanotherapeutics for treating ocular dryness. J Nanobiotechnol 2024; 22:160 [View Article]
     [Google Scholar]
  14. Szczotka-Flynn LB, Maguire MG, Ying G-S, Lin MC, Bunya VY et al. Impact of dry eye on visual acuity and contrast sensitivity: dry eye assessment and management study. Optom Vis Sci 2019; 96:387–396 [View Article] [PubMed]
     [Google Scholar]
  15. Lin P-H, Jian H-J, Li Y-J, Huang Y-F, Anand A et al. Alleviation of dry eye syndrome with one dose of antioxidant, anti-inflammatory, and mucoadhesive lysine-carbonized nanogels. Acta Biomater 2022; 141:140–150 [View Article] [PubMed]
     [Google Scholar]
  16. Periman LM, Mah FS, Karpecki PM. A review of the mechanism of action of cyclosporine A: the role of cyclosporine A in dry eye disease and recent formulation developments. Clin Ophthalmol 2020; 14:4187–4200 [View Article] [PubMed]
     [Google Scholar]
  17. Li Y-J, Luo L-J, Harroun SG, Wei S-C, Unnikrishnan B et al. Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease. Nanoscale 2019; 11:5580–5594 [View Article] [PubMed]
     [Google Scholar]
  18. Ghosh S, Su Y-H, Yang C-J, Lai J-Y. Design of highly adhesive urchin‐like gold nanostructures for effective topical drug administration and symptomatic relief of corneal dryness. Small Structures 2025; 6: [View Article]
     [Google Scholar]
  19. Mohamed HB, Abd El-Hamid BN, Fathalla D, Fouad EA. Current trends in pharmaceutical treatment of dry eye disease: a review. Eur J Pharm Sci 2022; 175:106206 [View Article] [PubMed]
     [Google Scholar]
  20. Kim J, Mondal H, Jin R, Yoon HJ, Kim H-J et al. Cellulose acetate phthalate-based pH-responsive cyclosporine A-loaded contact lens for the treatment of dry eye. Int J Mol Sci 2023; 24:2361 [View Article]
     [Google Scholar]
  21. Deshmukh R, Ting DSJ, Elsahn A, Mohammed I, Said DG et al. Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases. Br J Ophthalmol 2022; 106:1087–1092 [View Article] [PubMed]
     [Google Scholar]
  22. Hind J, Macdonald E, Lockington D. Real-world experience at a Scottish university teaching hospital regarding the tolerability and persistence with topical Ciclosporin 0.1% (Ikervis) treatment in patients with dry eye disease. Eye 2019; 33:685–686 [View Article] [PubMed]
     [Google Scholar]
  23. Branisteanu DC, Stoleriu G, Branisteanu DE, Boda D, Branisteanu CI et al. Ocular cicatricial pemphigoid (Review). Exp Ther Med 2020; 20:3379–3382 [View Article] [PubMed]
     [Google Scholar]
  24. Bartalena L, Tanda ML. Current concepts regarding Graves’ orbitopathy. J Intern Med 2022; 292:692–716 [View Article] [PubMed]
     [Google Scholar]
  25. Qian L, Wei W. Identified risk factors for dry eye syndrome: a systematic review and meta-analysis. PLoS One 2022; 17:e0271267 [View Article] [PubMed]
     [Google Scholar]
  26. Coles-Brennan C, Sulley A, Young G. Management of digital eye strain. Clin Exp Optom 2019; 102:18–29 [View Article] [PubMed]
     [Google Scholar]
  27. Sokół- Szawłowska M, Święcicki Ł, Czyżak I, Zdziechowska K. Self-mutilating behaviours in patients with mental disorders – a study on users of a social networking service. Psychiatr Pol 2015; 49:503–516 [View Article]
     [Google Scholar]
  28. Nowak R, Rekas M, Ali MJ. Long-term quality of life in patients following minimally invasive conjunctivodacryocystorhinostomy with StopLoss Jones tube. Ophthalmic Plast Reconst Surg 2022; 38:170–175 [View Article]
     [Google Scholar]
  29. Nowak R. Management of inferior dislocation of a StopLoss Jones tube after conjunctivodacryocystorhinostomy. BMJ Case Rep 2020; 13:e236003 [View Article]
     [Google Scholar]
  30. Maltsev D, Hurzhii O. Institute of Experimental and Clinical Medicine at the Bogomolets NMUAilas Clinic Toxoplasma chorioretinitis in primary myeloperoxidase MPO deficiency: a case report. Oftalmol Zh 2019; 81:75–81 [View Article]
     [Google Scholar]
  31. Suwała S, Szulc P, Guzowski C, Kamińska B, Dorobiała J et al. ChatGPT-3.5 passes Poland’s medical final examination—Is it possible for ChatGPT to become a doctor in Poland?. Sag Open Med 2024; 12:20503121241257777 [View Article]
     [Google Scholar]
  32. Carpio-Delgado FD, Bernedo-Moreira DH, Espiritu-Martinez AP, Aguilar-Cruzado JL, Joo-García CE et al. Telemedicine and eHealth solutions in clinical practice. EAI Endorsed Trans Perv Health Tech 2023; 9: [View Article]
     [Google Scholar]
  33. Carpio-Delgado FD, Romero-Carazas R, Pino-Espinoza GE, Villa-Ricapa LF, Núñez-Palacios EL et al. Telemedicine in Latin America: a bibliometric analysis. EAI Endorsed Trans Perv Health Tech 2023; 9:1–11 [View Article]
     [Google Scholar]
  34. Ouyang X, Yang J, Hong Z, Wu Y, Xie Y et al. Mechanisms of blue light-induced eye hazard and protective measures: a review. Biomed Pharmacother 2020; 130:110577 [View Article] [PubMed]
     [Google Scholar]
  35. Choo PP, Woi PJ, Bastion M-LC, Omar R, Mustapha M et al. Review of evidence for the usage of antioxidants for eye aging. Biomed Res Int 2022; 2022:5810373 [View Article] [PubMed]
     [Google Scholar]
  36. Sheppard J, Shen Lee B, Periman LM. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists. Ann Med 2023; 55:241–252 [View Article] [PubMed]
     [Google Scholar]
  37. Hasan ZAIY. Dry eye syndrome risk factors: a systemic review. Saudi J Ophthalmol 2022; 35:131–139 [View Article]
     [Google Scholar]
  38. Song A, Mousa HM, Soifer M, Perez VL. Recognizing vitamin A deficiency: special considerations in low-prevalence areas. Curr Opin Pediatr 2022; 34:241–247 [View Article] [PubMed]
     [Google Scholar]
  39. Vasyuta VA, Zhdanova VM, Kadzhaia MV. Structural analysis and etiological characteristics of oculomotor disorders in neurosurgical patients. Bull Med Biol Res 2022; 4:6–10 [View Article]
     [Google Scholar]
  40. Aliiev RB. Features of the endocrine activity of fat tissue in metabolism disorders. Bull Med Biol Res 2023; 5:26–32 [View Article]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001978
Loading
Impact of cyclosporine A on the progression of ocular surface diseases: treatment efficacy and potential complications
J. Med. Microbiol. 74, 001978 (2025); https://doi.org/10.1099/jmm.0.001978
/content/journal/jmm/10.1099/jmm.0.001978
/content/journal/jmm/10.1099/jmm.0.001978
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error